CCSB will continuously pursuit the goal of quality product, 
quality service and quality people to become a world-wide major supplier of high quality APIs with competitive prices.
　

  

Chunghwa Chemical Synthesis & Biotech  Co. Ltd. (CCSB) founded in 1964, is the largest bulk pharmaceutical manufacturer in Taiwan, located in  the suburb of Taipei

                         with a manufacturing  site of 8.7 acres.

　

CCSB is a member company of CHINA CHEMICAL PHARMACEUTICAL GROUP (CCPG). 

its affiliates, China Chemical Pharmaceutical Corporation (CCPC) in Taiwan and Suzhou

Chung-Hwa Chemical and Pharmaceutical Industrial Co. Ltd. (SCCPC) in Suzhou, China

constitute two of the largest pharmaceutical formulators in these areas.

The most recent investment to construct and upgrade these three companies amounts to $100

millions US dollars.

　

CCSB has developed more than 30 bulk pharmaceutical products including Anti-Anxiety agent; 

Antidiabetics; Laxatives; Antifungals; Antihistamines; Antiseptics; Antiulcerants; 

Cardiovascular drugs; Skeletal and muscle relaxants, Hypolipaemics and immunosuppresant.

In 1984, CCSB was the first pharmaceutical manufacturer in Taiwan inspected and approved 

by FDA for cGMP compliance. CCSB has filed DMF's for 13 products with the FDA. In April 2002,CCSB passed again the FDA inspection of their cGMP plant to produce synthesis and

biotechnology products. 

　

CCSB has established a sales office, in 1999 PHARMAPORTS   LLC in Montvale, New Jersey,

USA to promote its products and provide better services to the North American region.

Together, the group has formed an international network providing pharmaceutical ingredients 

and finished dosages.